Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Aryl Hydrocarbon Receptor Mediates Sensitivity of MCF-7 Breast Cancer Cells to Antitumor Agent 2-(4-Amino-3-methylphenyl) Benzothiazole

Andrea I. Loaiza-Pérez, Valentina Trapani, Curtis Hose, Sheo S. Singh, Jane B. Trepel, Malcolm F. G. Stevens, Tracey D. Bradshaw and Edward A. Sausville
Molecular Pharmacology January 2002, 61 (1) 13-19; DOI: https://doi.org/10.1124/mol.61.1.13
Andrea I. Loaiza-Pérez
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Trapani
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis Hose
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheo S. Singh
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane B. Trepel
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malcolm F. G. Stevens
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracey D. Bradshaw
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward A. Sausville
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 61 no. 1 13-19
DOI 
https://doi.org/10.1124/mol.61.1.13
PubMed 
11752201

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 6, 2001
  • Accepted October 1, 2001
  • Published online January 1, 2002.

Copyright & Usage 
U.S. Government

Author Information

  1. Andrea I. Loaiza-Pérez1,
  2. Valentina Trapani4,
  3. Curtis Hose2,
  4. Sheo S. Singh1,
  5. Jane B. Trepel3,
  6. Malcolm F. G. Stevens4,
  7. Tracey D. Bradshaw4, and
  8. Edward A. Sausville1
  1. 1Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Bethesda, Maryland (A.I.L.-P., S.S.S., E.A.S.) and 2Frederick, Maryland (C.H.); 3Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (J.B.T.); and 4Cancer Research Laboratories, School of Pharmaceutical Sciences, University of Nottingham, Nottingham, United Kingdom (V.T., T.D.B., M.F.G.S.)
  1. Dr. Andrea I. Loaiza-Pérez, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bldg. 10 Rm. 6N115, Bethesda, MD 20892. E-mail: loaizaa{at}pop.nci.nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2001 to September 2023

AbstractFullPdf
Dec 200129619
Jan 200236116111
Feb 200225950
Mar 200243518
Apr 200275229
May 200243425
Jun 200231410
Jul 200222420
Aug 200201011
Sep 20026206
Oct 200222538
Nov 200212018
Dec 20022116
Jan 200311411
Feb 2003086
Mar 200342434
Apr 200321516
May 200321216
Jun 200321212
Jul 200372920
Aug 200373423
Sep 2003132511
Oct 2003112332
Nov 2003163213
Dec 2003121912
Jan 2004182726
Feb 20047156
Mar 200414204
Apr 20048145
May 200413258
Jun 2004223516
Jul 2004192622
Aug 2004122813
Sep 200420295
Oct 200420289
Nov 2004143014
Dec 200414269
Jan 200519325
Feb 200519235
Mar 2005103517
Apr 200572310
May 200582316
Jun 200584017
Jul 2005102419
Aug 200582016
Sep 20051085
Oct 200581110
Nov 20059237
Dec 2005111411
Jan 200652912
Feb 20064266
Mar 20065158
Apr 20063124
May 2006575
Jun 20068165
Jul 20067126
Aug 2006111710
Sep 20062189
Oct 200622414
Nov 20063172
Dec 20065196
Jan 20074149
Feb 200752313
Mar 200782623
Apr 200772113
May 200742110
Jun 200761719
Jul 2007268
Aug 20076242
Sep 20072125
Oct 200732912
Nov 20076188
Dec 20072135
Jan 200861713
Feb 200832128
Mar 200851912
Apr 2008261615
May 2008101812
Jun 2008142112
Jul 2008242716
Aug 2008352814
Sep 2008172919
Oct 200815208
Nov 2008161411
Dec 20084135
Jan 2009101312
Feb 2009182510
Mar 2009132410
Apr 20099136
May 200912239
Jun 20093129
Jul 200911173
Aug 200991712
Sep 200912116
Oct 2009122214
Nov 2009464
Dec 2009370
Jan 2010785
Feb 20106168
Mar 2010142412
Apr 201012228
May 2010142610
Jun 2010163614
Jul 2010121411
Aug 2010887
Sep 201018146
Oct 20109126
Nov 20106196
Dec 201012158
Jan 20117118
Feb 2011324310
Mar 201110147
Apr 201111610
May 2011141422
Jun 2011888
Jul 2011758
Aug 201191610
Sep 201111288
Oct 201113229
Nov 201114228
Dec 20119139
Jan 201292110
Feb 201214244
Mar 2012102115
Apr 2012153415
May 2012111711
Jun 201281411
Jul 201215911
Aug 20121055
Sep 20127118
Oct 20127711
Nov 201216811
Dec 201214912
Jan 201322166
Feb 2013182319
Mar 201371513
Apr 201317914
May 201321513
Jun 2013749
Jul 201314113
Aug 2013238
Sep 20139211
Oct 201316711
Nov 20132425
Dec 2013035
Jan 2014904
Feb 20148812
Mar 20147510
Apr 20148611
May 201414721
Jun 2014958
Jul 20141085
Aug 2014434
Sep 20141128
Oct 201413104
Nov 2014774
Dec 2014822
Jan 20156122
Feb 20151021
Mar 20158147
Apr 2015853
May 20158116
Jun 20151062
Jul 201517139
Aug 20151185
Sep 20151053
Oct 20151142
Nov 2015923
Dec 20151535
Jan 2016944
Feb 20162186
Mar 201613414
Apr 20162163
May 2016872
Jun 201681013
Jul 20169114
Aug 20168107
Sep 2016462
Oct 20162176
Nov 20160193
Dec 2016488
Jan 20171143
Feb 20173115
Mar 20171131
Apr 20170152
May 20171155
Jun 20173218
Jul 20172208
Aug 201712910
Sep 20171216
Oct 201701814
Nov 20173244
Dec 20173213
Jan 20181182
Feb 2018111512
Mar 201812110
Apr 20185289
May 201832913
Jun 20182237
Jul 201831610
Aug 20180654
Sep 20180365
Oct 201842913
Nov 20181446
Dec 201837105
Jan 20194400
Feb 20194511
Mar 20192600
Apr 20193421
May 20191822
Jun 2019913
Jul 20191142
Aug 20192824
Sep 20192211
Oct 20191644
Nov 20191802
Dec 20192200
Jan 20201030
Feb 20201101
Mar 20201100
Apr 2020811
May 20201400
Jun 20201400
Jul 2020911
Aug 20201301
Sep 20201000
Oct 20201213
Nov 2020510
Dec 20201300
Jan 20211372
Feb 2021760
Mar 20212210
Apr 2021611
May 20212031
Jun 2021530
Jul 2021710
Aug 20211230
Sep 20211032
Oct 2021920
Nov 20211020
Dec 20211310
Jan 20221610
Feb 20221220
Mar 2022610
Apr 2022820
May 2022831
Jun 20221532
Jul 20221010
Aug 20221130
Sep 2022652
Oct 20221020
Nov 2022820
Dec 20221642
Jan 20233340
Feb 20231041
Mar 20231120
Apr 2023800
May 20231320
Jun 2023710
Jul 20231930
Aug 2023310
Sep 20231310

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 61 (1)
Molecular Pharmacology
Vol. 61, Issue 1
1 Jan 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aryl Hydrocarbon Receptor Mediates Sensitivity of MCF-7 Breast Cancer Cells to Antitumor Agent 2-(4-Amino-3-methylphenyl) Benzothiazole
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Aryl Hydrocarbon Receptor Mediates Sensitivity of MCF-7 Breast Cancer Cells to Antitumor Agent 2-(4-Amino-3-methylphenyl) Benzothiazole

Andrea I. Loaiza-Pérez, Valentina Trapani, Curtis Hose, Sheo S. Singh, Jane B. Trepel, Malcolm F. G. Stevens, Tracey D. Bradshaw and Edward A. Sausville
Molecular Pharmacology January 1, 2002, 61 (1) 13-19; DOI: https://doi.org/10.1124/mol.61.1.13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Aryl Hydrocarbon Receptor Mediates Sensitivity of MCF-7 Breast Cancer Cells to Antitumor Agent 2-(4-Amino-3-methylphenyl) Benzothiazole

Andrea I. Loaiza-Pérez, Valentina Trapani, Curtis Hose, Sheo S. Singh, Jane B. Trepel, Malcolm F. G. Stevens, Tracey D. Bradshaw and Edward A. Sausville
Molecular Pharmacology January 1, 2002, 61 (1) 13-19; DOI: https://doi.org/10.1124/mol.61.1.13
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics